Choi et al. reported that RBP4 was higher in RCC cases than that in healthy controls [11], while the lower serum RBP4 level was correlated with unfavorable overall survival (OS) and disease-free survival (DFS) according to Sobotka's data [12]. This evidence concerns the gene RBP4 and renal cell carcinoma.